Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

What Does Atrial Fibrillation Mean in Patients With Cardiac Implantable Electronic Devices?

  • Jae-Sun Uhm (Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine)
  • Received : 2023.11.28
  • Accepted : 2023.12.05
  • Published : 2024.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Joung B. Risk factor management for atrial fibrillation. Korean Circ J 2019;49:794-807.
  2. Kim M, Kim J, Kim JB, et al. Association of gender with clinical outcomes in a contemporary cohort of patients with atrial fibrillation receiving oral anticoagulants. Korean Circ J 2022;52:593-603.
  3. Lee H, Kim TH, Baek YS, et al. The trends of atrial fibrillation-related hospital visit and cost, treatment pattern and mortality in Korea: 10-year nationwide sample cohort data. Korean Circ J 2017;47:56-64.
  4. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498.
  5. Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation 2017;136:1784-94.
  6. William AD, Kanbour M, Callahan T, et al. Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: the iREAD study. Heart Rhythm 2018;15:1561-5.
  7. Yoon M, Oh J, Chun KH, et al. Clinical implications of device-detected atrial fibrillation in cardiac resynchronization therapy. Korean Circ J 2023;53:483-96.
  8. Gorenek B, Bax J, Boriani G, et al. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace 2017;19:1556-78.
  9. Perino AC, Fan J, Askari M, et al. Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation. Circulation 2019;139:2502-12.
  10. Lee SR, Lee JH, Choi EK, et al. Risk of atrial fibrillation and adverse outcomes in patients with cardiac implantable electronic devices. Korean Circ J 2024;54:13-27.